Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study.
Lu K, Liao QQ, Zhu KW, Yao Y, Cui XJ, Chen P, Bi Y, Zhong M, Zhang H, Tang JC, Yu Q, Yue JK, He H, Zhu ZF, Cai ZZ, Yang Z, Zhang W, Dong YT, Wei QM, He X.
Lu K, et al. Among authors: zhang w, zhang h.
Adv Ther. 2024 Jan;41(1):391-412. doi: 10.1007/s12325-023-02717-5. Epub 2023 Nov 21.
Adv Ther. 2024.
PMID: 37987918